FdaApplication

NDA 205579

Back to search

Identifiers

Properties

PropertyValue
applicant_nameEAGLE PHARMACEUTICALS INC
application_typeNDA
approval_date2014-07-22

Products (1)

ProductActive ingredientStrengthDosage form
RYANODEXDANTROLENE SODIUM250MG/VIALFOR SUSPENSION;INTRAVENOUS

1 product